156 related articles for article (PubMed ID: 12007627)
1. Urocortin.
Latchman DS
Int J Biochem Cell Biol; 2002 Aug; 34(8):907-10. PubMed ID: 12007627
[TBL] [Abstract][Full Text] [Related]
2. Urocortin-II and urocortin-III are cardioprotective against ischemia reperfusion injury: an essential endogenous cardioprotective role for corticotropin releasing factor receptor type 2 in the murine heart.
Brar BK; Jonassen AK; Egorina EM; Chen A; Negro A; Perrin MH; Mjøs OD; Latchman DS; Lee KF; Vale W
Endocrinology; 2004 Jan; 145(1):24-35; discussion 21-3. PubMed ID: 12970163
[TBL] [Abstract][Full Text] [Related]
3. Urocortin expression in rat brain: evidence against a pervasive relationship of urocortin-containing projections with targets bearing type 2 CRF receptors.
Bittencourt JC; Vaughan J; Arias C; Rissman RA; Vale WW; Sawchenko PE
J Comp Neurol; 1999 Dec; 415(3):285-312. PubMed ID: 10553117
[TBL] [Abstract][Full Text] [Related]
4. Urocortin II: a member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors.
Reyes TM; Lewis K; Perrin MH; Kunitake KS; Vaughan J; Arias CA; Hogenesch JB; Gulyas J; Rivier J; Vale WW; Sawchenko PE
Proc Natl Acad Sci U S A; 2001 Feb; 98(5):2843-8. PubMed ID: 11226328
[TBL] [Abstract][Full Text] [Related]
5. Protective effects of the urocortin homologues stresscopin (SCP) and stresscopin-related peptide (SRP) against hypoxia/reoxygenation injury in rat neonatal cardiomyocytes.
Chanalaris A; Lawrence KM; Stephanou A; Knight RD; Hsu SY; Hsueh AJ; Latchman DS
J Mol Cell Cardiol; 2003 Oct; 35(10):1295-305. PubMed ID: 14519439
[TBL] [Abstract][Full Text] [Related]
6. The neurobiology of urocortin.
Skelton KH; Owens MJ; Nemeroff CB
Regul Pept; 2000 Sep; 93(1-3):85-92. PubMed ID: 11033056
[TBL] [Abstract][Full Text] [Related]
7. Urocortins: putative role in cardiovascular disease.
Charles CJ; Rademaker MT; Richards AM
Curr Med Chem Cardiovasc Hematol Agents; 2004 Jan; 2(1):43-7. PubMed ID: 15320806
[TBL] [Abstract][Full Text] [Related]
8. Urocortins and corticotropin releasing factor type 2 receptors in the hypothalamus and the cardiovascular system.
Hashimoto K; Nishiyama M; Tanaka Y; Noguchi T; Asaba K; Hossein PN; Nishioka T; Makino S
Peptides; 2004 Oct; 25(10):1711-21. PubMed ID: 15476938
[TBL] [Abstract][Full Text] [Related]
9. Delayed satiety-like actions and altered feeding microstructure by a selective type 2 corticotropin-releasing factor agonist in rats: intra-hypothalamic urocortin 3 administration reduces food intake by prolonging the post-meal interval.
Fekete EM; Inoue K; Zhao Y; Rivier JE; Vale WW; Szücs A; Koob GF; Zorrilla EP
Neuropsychopharmacology; 2007 May; 32(5):1052-68. PubMed ID: 17019404
[TBL] [Abstract][Full Text] [Related]
10. Urocortins and the regulation of gastrointestinal motor function and visceral pain.
Martinez V; Wang L; Million M; Rivier J; Taché Y
Peptides; 2004 Oct; 25(10):1733-44. PubMed ID: 15476940
[TBL] [Abstract][Full Text] [Related]
11. Urocortin protects against ischemic injury via a MAPK-dependent pathway.
Latchman DS
Trends Cardiovasc Med; 2001 Jul; 11(5):167-9. PubMed ID: 11597826
[TBL] [Abstract][Full Text] [Related]
12. Role of corticotropin-releasing factor and urocortin within the basolateral amygdala of rats in anxiety and panic responses.
Sajdyk TJ; Schober DA; Gehlert DR; Shekhar A
Behav Brain Res; 1999 Apr; 100(1-2):207-15. PubMed ID: 10212068
[TBL] [Abstract][Full Text] [Related]
13. Urocortin 2 acts centrally to delay gastric emptying through sympathetic pathways while CRF and urocortin 1 inhibitory actions are vagal dependent in rats.
Czimmer J; Million M; Taché Y
Am J Physiol Gastrointest Liver Physiol; 2006 Mar; 290(3):G511-8. PubMed ID: 16223946
[TBL] [Abstract][Full Text] [Related]
14. Urocortins as cardiovascular peptides.
Takahashi K; Totsune K; Murakami O; Shibahara S
Peptides; 2004 Oct; 25(10):1723-31. PubMed ID: 15476939
[TBL] [Abstract][Full Text] [Related]
15. Urocortin: a cardiac protective peptide?
Tao J; Li S
Biochem Biophys Res Commun; 2005 Jul; 332(4):923-6. PubMed ID: 15949465
[TBL] [Abstract][Full Text] [Related]
16. Urocortin expression in the Edinger-Westphal nucleus is down-regulated in transgenic mice over-expressing neuronal corticotropin-releasing factor.
Kozicz T; Korosi A; Korsman C; Tilburg-Ouwens D; Groenink L; Veening J; van Der Gugten J; Roubos E; Olivier B
Neuroscience; 2004; 123(3):589-94. PubMed ID: 14706771
[TBL] [Abstract][Full Text] [Related]
17. Expression of urocortin and corticotropin-releasing factor receptor subtypes in the human heart.
Kimura Y; Takahashi K; Totsune K; Muramatsu Y; Kaneko C; Darnel AD; Suzuki T; Ebina M; Nukiwa T; Sasano H
J Clin Endocrinol Metab; 2002 Jan; 87(1):340-6. PubMed ID: 11788672
[TBL] [Abstract][Full Text] [Related]
18. Urocortin, corticotropin releasing factor-2 receptors and energy balance.
Cullen MJ; Ling N; Foster AC; Pelleymounter MA
Endocrinology; 2001 Mar; 142(3):992-9. PubMed ID: 11181511
[TBL] [Abstract][Full Text] [Related]
19. Microinjection of urocortin into the rat nucleus tractus solitarii decreases arterial blood pressure.
Yamazaki T; Waki H; Kohsaka A; Nakamura T; Cui H; Yukawa K; Maeda M
Auton Neurosci; 2008 Nov; 142(1-2):51-4. PubMed ID: 18804421
[TBL] [Abstract][Full Text] [Related]
20. The interaction of Urocortin II and Urocortin III with amygdalar and hypothalamic cotricotropin-releasing factor (CRF)--reflections on the regulation of the hypothalamic-pituitary-adrenal (HPA) axis.
Bagosi Z; Csabafi K; Palotai M; Jászberényi M; Földesi I; Gardi J; Szabó G; Telegdy G
Neuropeptides; 2013 Oct; 47(5):333-8. PubMed ID: 23932308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]